Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
17.54
+0.36 (2.07%)
At close: Jul 24, 2026, 4:00 PM EDT
17.63
+0.09 (0.54%)
After-hours: Jul 24, 2026, 7:34 PM EDT
Trevi Therapeutics Market Cap
Trevi Therapeutics has a market cap or net worth of $2.49 billion as of July 24, 2026. Its market cap has increased by 164.84% in one year.
Market Cap
2.49B
Enterprise Value
2.32B
1-Year Change
164.84%
Ranking
Category
Stock Price
$17.54
ChartMarket Cap Chart
Since May 7, 2019, Trevi Therapeutics's market cap has increased from $84.99M to $2.49B, an increase of 2,829.33%. That is a compound annual growth rate of 59.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 2.49B | 55.07% |
| Dec 31, 2025 | 1.61B | 336.04% |
| Dec 31, 2024 | 368.19M | 330.28% |
| Dec 29, 2023 | 85.57M | -26.01% |
| Dec 30, 2022 | 115.65M | 472.04% |
| Dec 31, 2021 | 20.22M | -54.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beam Therapeutics | 2.58B |
| Kodiak Sciences | 2.56B |
| Tarsus Pharmaceuticals | 2.52B |
| Immunome | 2.49B |
| Nurix Therapeutics | 2.46B |
| SELLAS Life Sciences Group | 2.43B |
| Mineralys Therapeutics | 2.38B |
| Nektar Therapeutics | 2.34B |